- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sphincter of Oddi Function in New Zealand
Total 123 results
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedSphincter of Oddi DysfunctionUnited States
-
Hospital for Special Surgery, New YorkCompletedReturn of Bowel Function Following Spinal SurgeryUnited States
-
Schroppel, Bernd, M.D.Alexion PharmaceuticalsTerminatedDelayed Function of Renal TransplantUnited States
-
Smith & Nephew, Inc.RecruitingAvascular Necrosis | Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis | Requires Correction of Functional Deformity | Requires Treatment of Fractures That Were Unmanageable Using Other TechniquesNew Zealand, Australia, Hong Kong
-
University of RochesterNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAlteration of Cognitive Function | Age-associated Memory ImpairmentUnited States
-
Prolong PharmaceuticalsCompletedDelayed Function of Renal TransplantUnited States
-
Faeth TherapeuticsActive, not recruitingAdvanced Solid Tumor | PIK3CA Mutation | PTEN Loss of Function MutationUnited States
-
University of RochesterCompletedFunctional Disorder of IntestineUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDyspepsia and Other Specified Disorders of Function of StomachUnited States, Canada
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | Fatigue | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentBelgium, Switzerland, United Kingdom, Australia, Italy, New Zealand
-
Quark PharmaceuticalsCompletedDelayed Graft Function | Other Complication of Kidney TransplantUnited States, Spain, Germany, France, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingUnspecified Adult Solid Tumor, Protocol Specific | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedEsophageal Cancer | Malignant Neoplasm of Cardio-esophageal Junction of StomachUnited States
-
Rutgers, The State University of New JerseyUtah State UniversityCompletedIncreasing Functional Communicative Behavior | Decreasing Destructive Behavior | Analysis of Treatment Dosage | Empirically Determined Reinforcement Schedule ThinningUnited States
-
Stockton UniversityCompletedQuality of Life | Pain | Cancer Survivor | Balance | Function | Fall Risk | Chemotherapy Induced Peripheral NeuropathyUnited States
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Yale UniversityFood and Drug Administration (FDA)Active, not recruitingQuality of Life | Lymphoma | Cancer, Breast | Physical Function | Patient Empowerment | Patient EducationUnited States
-
Yale UniversitySpectranetics CorporationCompletedC.Surgical Procedure; Cardiac | Cardiac Dysrhythmia | Disorder of Pacing FunctionUnited States
-
Endeavor Biomedicines, Inc.Active, not recruitingSolid Tumors With PTCH1 Loss-of-function MutationsUnited States
-
State University of New York - Upstate Medical...RecruitingStroke | Sleep Wake Disorders | Rehabilitation | Recovery of FunctionUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric CancerUnited States
-
The Cooper Health SystemRecruitingQuality of Life | Irritable Bowel Syndrome | AnxietyUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Stage III Esophageal CancerUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIB Gastric Cancer | Stage IIIC Gastric CancerUnited States
-
State University of New York College of OptometryState University of New York College of OptometryRecruitingQuality of Life | Visual Impairment | Functional Visual Loss | Low Vision BlindnessUnited States
-
Heinrich-Heine University, DuesseldorfUniversity Hospital of CologneRecruitingCancer of Esophagus | Esophagogastric Junction DisorderGermany
-
Gulam ManjiMerck Sharp & Dohme LLCCompletedGastric Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
PrecirixActive, not recruitingAdvanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care TreatmentUnited States, Canada
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric CancerUnited States
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma... and other conditionsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Bristol-Myers SquibbCompletedGastric Cancer | Esophagogastric Junction | Cancer of the StomachUnited States, Germany, Italy, Argentina, Australia, Belgium, France, Poland, Puerto Rico, Spain, Czechia, Austria, Canada, United Kingdom, Chile, Norway, Singapore
-
Astellas Pharma Global Development, Inc.RecruitingGastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)United States, Italy, Japan, Korea, Republic of, Taiwan, France
-
Yale UniversityRecruiting
-
Epizyme, Inc.CompletedMesothelioma | BAP1 Loss of FunctionUnited States, United Kingdom, France
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)TerminatedAdenocarcinoma of the Gastroesophageal Junction | Stage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal Adenocarcinoma | Stage IIB Esophageal AdenocarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedGastric Cancer | Gastric Adenocarcinoma | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Imugene LimitedActive, not recruitingStomach Cancer | Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Cancer of Stomach | Stomach AdenocarcinomaTaiwan, Australia
-
Duke UniversityPatient-Centered Outcomes Research Institute; Beth Israel Deaconess Medical...CompletedAutoimmune Diseases | Neurological DisorderUnited States, Canada
-
Rapa Therapeutics LLCRecruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Solid Tumor | Bladder Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Malignant Melanoma | Carcinoma of Unknown Primary | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of Oral Cavity | Squamous Cell Carcinoma of Nasopharynx and other conditionsUnited States
-
Louis H. Weimer, MDNo longer availableLambert Eaton Myasthenic Syndrome (LEMS)United States
-
Abbott Medical DevicesActive, not recruitingHeart Failure | Mitral Regurgitation | Mitral Valve Regurgitation | Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure SubjectsUnited States, Canada
-
University of VermontGenentech, Inc.Completed
-
argenxApproved for marketingGeneralized Myasthenia GravisUnited States
-
Leap Therapeutics, Inc.Merck Sharp & Dohme LLCCompletedEsophageal Neoplasms | Gastric Adenocarcinoma | Adenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma | Gastroesophageal CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Cancer Survivor | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Sexuality and Reproductive Issues | Spiritual ConcernsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); AmgenCompletedEsophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Michael BenatarUniversity of Miami; University of RochesterTerminatedOcular Myasthenia GravisUnited States, Canada